
Peptic Ulcer Disease (PUD): Gastric Ulcer vs Duodenal Ulcer
A Complete Guide to Symptoms, Diagnosis & Latest Treatment.
What is Peptic Ulcer Disease?
Peptic ulcer disease (PUD) refers to a defect or break in the mucosal lining of the stomach or duodenum that extends through the muscularis mucosa due to the corrosive action of gastric acid and pepsin.
The two major types are:
Gastric ulcer (GU): Ulcer located in the stomach.
Duodenal ulcer (DU): Ulcer located in the first part of the duodenum.
The majority of peptic ulcers are caused by Helicobacter pylori (H. pylori) infection and long-term NSAID use.
Most common cause worldwide:
• NSAIDs
• Aspirin
• Ibuprofen
• Diclofenac
• Naproxen
Other causes:
• Smoking
• Alcohol
• Severe physiological stress (stress ulcers)
• Zollinger–Ellison syndrome
• Corticosteroids (especially with NSAIDs)
Symptoms:
Common symptoms:
Burning epigastric pain
Upper abdominal discomfort
Nausea
Bloating
Early satiety
Heartburn
Belching
Gastric ulcer
Pain increases after eating
Weight loss
Loss of appetite
Duodenal ulcer
Pain relieved after meals
Night-time pain
Hunger pain
Weight gain
Alarm Symptoms (Red Flags)
These require urgent endoscopy:
GI bleeding
Hematemesis
Melena
Iron deficiency anemia
Persistent vomiting
Dysphagia
Unexplained weight loss
Palpable abdominal mass
Age >60 years with new-onset dyspepsia (guideline-dependent)
Clinical Examination:
May be completely normal.
Possible findings:
Epigastric tenderness
Pallor (anemia)
Signs of dehydration
Signs of perforation (guarding and rigidity)
Hypotension in severe GI bleeding
Investigations:
Blood tests
CBC
Iron studies
Urea and creatinine
Liver function tests
CRP (if indicated)
H. pylori Tests
Non-invasive
Urea breath test (highest accuracy after treatment)
Stool antigen test
Serology (not recommended to confirm eradication)
Invasive
Rapid urease test
Histology
Culture (rarely required)
Upper GI Endoscopy (OGD)
Gold Standard Investigation:
Upper gastrointestinal endoscopy is the gold standard for diagnosing peptic ulcer disease.
It allows:
Direct visualization
Biopsy
Detection of bleeding
Therapeutic intervention
Important: Every gastric ulcer should be biopsied to exclude gastric carcinoma.
Approach to a Patient with Suspected Peptic Ulcer:
Take a detailed history.
Assess alarm symptoms.
Perform physical examination.
Test for H. pylori (if appropriate).
Arrange upper GI endoscopy when indicated.
Stop NSAIDs if possible.
Start proton pump inhibitor (PPI).
Eradicate H. pylori if positive.
Confirm eradication (urea breath test or stool antigen) at least 4 weeks after antibiotics and after withholding PPIs for about 2 weeks.
Complications:
Upper GI bleeding
Perforation
Gastric outlet obstruction
Penetration into adjacent organs
Gastric carcinoma (gastric ulcers)
Treatment:
General Measures
Stop NSAIDs
Smoking cessation
Avoid alcohol
Avoid ulcerogenic drugs where possible
First-Line H. pylori Eradication Therapy:
Because clarithromycin resistance is high in many regions, many current guidelines prefer bismuth quadruple therapy as the empiric first-line regimen unless local susceptibility is known.
Bismuth Quadruple Therapy (Preferred Empiric Regimen)
Duration: 14 days:
( Mnemonic: TOMB)
• Omeprazole 20 mg orally twice daily (or equivalent PPI)
• Bismuth subcitrate 120–300 mg four times daily (or bismuth subsalicylate 300–524 mg four times daily)
• Tetracycline 500 mg four times daily
• Metronidazole 500 mg three to four times daily
Clarithromycin Triple Therapy:
Use only when clarithromycin susceptibility is known or local resistance is low (<15%) and there has been no prior macrolide exposure.
Duration: 14 days
(Mnemonic: CAP)
• Omeprazole 20 mg twice daily
• Amoxicillin 1 g twice daily
• Clarithromycin 500 mg twice daily
Penicillin allergy
Replace Amoxicillin with Metronidazole 500 mg twice daily
If Initial Therapy Fails
Use a regimen that avoids antibiotics previously taken, such as:
Optimized bismuth quadruple therapy (if not used initially)
Rifabutin-based triple therapy
Vonoprazan-based regimens (where available)
Susceptibility-guided therapy after culture or molecular testing
Duration of PPI Therapy
Duodenal ulcer
Continue PPI for approximately 4 weeks.
Gastric ulcer
Continue PPI for approximately 8 weeks, with repeat endoscopy to document healing and exclude malignancy.
Prevention:
Eradicate H. pylori
Avoid unnecessary NSAIDs
Use PPIs for gastroprotection in high-risk NSAID users
Stop smoking
Limit alcohol intake
Key Exam Pearls:
• Upper GI endoscopy is the gold standard for diagnosis.
• Biopsy every gastric ulcer to rule out malignancy.
• Duodenal ulcers are rarely malignant.
• H. pylori causes about 90% of duodenal ulcers and about 70% of gastric ulcers.
• Bismuth quadruple therapy for 14 days is the preferred empiric first-line regimen in many regions because of rising clarithromycin resistance.
• Confirm H. pylori eradication after treatment with a urea breath test or stool antigen test.
References:
This article is based on recommendations from the following authoritative sources:
American College of Gastroenterology (ACG). Clinical Guideline: Treatment of Helicobacter pylori Infection (2024 Update).
American Gastroenterological Association (AGA). Clinical Practice Updates on Peptic Ulcer Disease.
Maastricht VI/Florence Consensus Report (2022) on the Management of Helicobacter pylori Infection.
National Institute for Health and Care Excellence (NICE). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (CG184).
Harrison’s Principles of Internal Medicine, 22nd Edition.
Robbins & Cotran Pathologic Basis of Disease, 10th Edition.
Schwartz’s Principles of Surgery, 12th Edition.
This structure is well suited for publication on your MED LEARNERS website and is aligned with current international guidance.

